How to Manage GLP-1 Side Effects: A Practical Symptom Checklist
Small meal changes may help mild nausea, but persistent symptoms need your prescriber. A practical checklist for symptoms, hydration, dose questions and warning signs.
Summarize this article with

Key takeaway
Small meal changes may help mild nausea, but persistent symptoms need your prescriber. A practical checklist for symptoms, hydration, dose questions and warning signs.
In this article
- 01Which symptoms need urgent medical help?
- 02What can help mild GLP-1 nausea?
- 03What should you do about diarrhea or vomiting?
- 04What can help constipation without guessing at supplements?
- 05Should you change your dose when side effects appear?
- 06What about fatigue, hair changes or symptoms that last?
- 07What should you record before contacting your prescriber?
- 08Frequently asked questions about managing GLP-1 side effects
- 09Sources
Managing GLP-1 side effects starts with checking how serious the symptoms are, then contacting your prescriber when they persist or interfere with drinking, eating or daily life. For mild nausea, smaller portions, slower eating and bland, lower-fat foods may help. Constipation and diarrhea need different responses; do not treat every stomach symptom with the same supplement. Keep a note of your medication, dose, last dose change and symptoms so your clinician can advise you. Severe ongoing abdominal pain, breathing difficulty, collapse or signs of dehydration need urgent assessment. Do not wait for a set number of hours or change your dose based on an online checklist. This guide helps you prepare that conversation; it cannot diagnose the cause of your symptoms.
The safety boundaries come from the Wegovy prescribing information and Zepbound Medication Guide. For percentages and treatment-group details, use our separate GLP-1 side-effect rates guide. For day-to-day notes, open the side-effect tracker.
Which symptoms need urgent medical help?
Severe symptoms belong in a clinical conversation, not a home-remedy experiment. The Zepbound Medication Guide identifies the following warning signs. Read the Medication Guide for your own prescription too, because instructions can differ between products.
- •Breathing difficulty, swelling of the face or throat, or collapse: get emergency help. Call 911 for trouble breathing or collapse.
- •Severe abdominal pain that does not go away, with or without vomiting: contact a healthcare professional immediately. Wegovy and Zepbound instructions say to stop treatment when pancreatitis is suspected; the pain may reach your back.
- •Repeated vomiting, inability to drink, or markedly reduced urination: seek prompt medical advice for possible dehydration. Do not use a 24-hour waiting rule.
- •Upper abdominal pain with fever, jaundice or pale stools: contact a clinician promptly for possible gallbladder problems.
- •Severe confusion, fainting or a seizure: seek emergency help. Tell responders about insulin or other diabetes medicines you take.
When you call, say what happened and when, rather than guessing a diagnosis. If you are too unwell to explain it yourself, ask someone with you to read your medication label to the clinician. An online tracker is optional; getting help comes first.
What can help mild GLP-1 nausea?
Start with meal size and comfort, then tell your prescriber if nausea keeps bothering you. Novo Nordisk’s nausea guidance suggests bland, low-fat foods, slower eating and avoiding lying down after meals. It also encourages discussion of smaller, more frequent meals and hydration with your healthcare professional.
- •Choose a smaller portion and stop when you feel full. You can describe which foods you tolerate instead of trying to follow a rigid meal count.
- •Try a simple food you already tolerate, such as toast or rice. Record whether greasy meals seem to make the problem worse.
- •Stay upright after eating. Take your prescribed medicine according to its own instructions; injection advice does not replace the fasting rules for an oral medicine.
- •Ask your prescriber what to do if nausea makes it hard to eat or drink. A prescription anti-nausea medicine is a clinical decision.
Change one manageable thing at a time and note the result. If you change meals, injection timing and several supplements together, your notes will not tell you which change helped. There is no verified universal evening-injection trick or predictable six-hour nausea window in the sources used here. A pattern you notice is something to discuss, not a rule for everyone.
For meal ideas to discuss, see foods that may be harder to tolerate on a GLP-1. If symptoms become severe, return to the warning signs above rather than continuing food experiments.
What should you do about diarrhea or vomiting?
Pay attention to fluid loss and whether symptoms are continuing. NIDDK’s diarrhea guidance discusses replacing fluids and electrolytes. It advises older adults and people with diabetes, kidney disease or other health conditions to ask a clinician about appropriate rehydration solutions and amounts.
A useful message to your prescriber includes how often vomiting or loose stools occurred, whether you can keep drinks down, and whether you are urinating less than usual. “Three episodes since breakfast; I can drink but feel dizzy when standing” is more informative than “the medicine is making me sick.” This is an example of clear reporting, not a threshold that makes symptoms safe.
- •Ask which fluids and foods fit your medical history. Follow any fluid restriction you have been given.
- •Ask before adding an anti-diarrheal medicine if you have fever, blood in your stool or persistent symptoms. Do not assume every episode is caused by your GLP-1.
- •Do not wait for symptoms to meet a three-day rule if you cannot drink or are becoming unwell.
The Zepbound prescribing information warns that gastrointestinal symptoms can lead to dehydration and kidney injury. A plan for the next dose should come from your prescriber, especially if a dose increase is due while you are still unwell.
What can help constipation without guessing at supplements?
Discuss food, fluids, activity and any medicine you may need. NIDDK’s constipation guidance supports fiber-containing foods, suitable fluid intake and regular activity. It also says a healthcare professional can recommend an appropriate laxative for short-term use and that medicines should not be changed without advice.
Write down your last bowel movement, how different this is from your usual pattern, and whether you also have pain, vomiting or trouble eating. Bring a list of medicines and supplements, including anything you have already tried. The goal is to give the clinician a usable picture, not to assign yourself a constipation score.
- •Ask how to adjust fiber and fluids for your situation rather than following a universal two-liter target.
- •If a clinician recommends a product, confirm which one, how much, how long to use it and when to call back.
- •Avoid stacking a fiber supplement, magnesium and a laxative just because they appeared together on a checklist.
- •Seek assessment for significant pain, vomiting or symptoms that are worsening instead of repeatedly adding remedies.
An over-the-counter label is not a personalized recommendation. Keep the packet or a photo of the ingredients so a pharmacist or prescriber can review exactly what you used.
Should you change your dose when side effects appear?
Ask the prescriber before a planned increase if symptoms are still troublesome. The Wegovy prescribing information allows a clinician to consider delaying escalation when a dose is not tolerated. The Zepbound prescribing information directs clinicians to consider response and tolerability when choosing a maintenance dose. These are product-specific instructions, not permission to design your own schedule.
Have the medication name, administration form, strength and date of your last dose ready. A starter dose, maintenance dose and missed-dose instruction are different things. Do not substitute a rule from another medicine, split a pen, double a dose or make up a taper from an internet post.
Useful questions are: “Does this change the plan for my next dose?”, “Who should I contact outside office hours?” and “Which symptom should make me seek urgent care?” Write down the answer in your own words and repeat it back if the plan is unclear. Our dosing timeline can help you read the usual schedule alongside your prescription; it cannot authorize a dose change.
If you think your last dose was taken incorrectly, tell the prescriber or pharmacist the exact product and amount instead of trying to compensate yourself.
What about fatigue, hair changes or symptoms that last?
Report persistent symptoms rather than assuming they are a normal adjustment. The Wegovy prescribing information lists fatigue and hair loss among reported adverse reactions, but a list of possible effects does not establish the cause in an individual person. Bring the onset, changes over time and any medicines or supplements you use to your clinician.
This guide does not prescribe a calorie floor, protein target, biotin dose or muscle-preservation supplement. Those choices depend on your health, intake and clinical assessment. If you cannot eat adequately, that difficulty itself is information your care team needs. A new symptom deserves attention even if you have been taking the medicine for months.
There is also an important correction to older safety information: in January 2026, FDA requested removal of the suicidal-behavior and ideation warning from affected GLP-1 weight-management labels after its review found no increased risk. New or worsening mental-health symptoms still deserve care. If you are in emotional distress or thinking about suicide, call or text 988 in the US; use 911 for immediate danger.
Describe what changed without trying to prove that the medicine caused it. Your clinician can decide whether the next step is an examination, tests, nutrition support, a treatment change or another explanation.
What should you record before contacting your prescriber?
Use one short note that connects the prescription, symptom and question. Our side-effect tracker records symptoms on your device and offers an export. It does not send a message to your clinician or monitor you. You must share the information yourself. The example below is an editorial checklist for that conversation, not a diagnostic tool.
| Record | Example or prompt |
|---|---|
| Prescription | Name, form, strength, last dose date and most recent increase |
| Symptom | What happened, when it began, how often and whether it is worsening |
| Daily impact | Can you drink, eat, sleep and do usual activities? |
| Other context | Other medicines, supplements, recent illness and anything already tried |
| Your question | What should I do now, and does the next dose need a different plan? |
You can copy this message: “I take [medicine, form and strength]. My last dose was [date], and my last increase was [date]. Since [time], I have had [symptom and frequency]. I can/cannot [drink, eat or do usual activities]. I have tried [steps]. I also take [medicines or supplements]. Please advise what to do now and about my next dose.”
This supports the request in the Zepbound Medication Guide to report effects that bother you or do not go away. You do not need a complete diary before making contact. If you are experiencing a warning sign, call for help instead of filling in every field.
Frequently asked questions about managing GLP-1 side effects
Do side effects always disappear after four to eight weeks? No fixed timeline applies to everyone. The Zepbound prescribing information says nausea, vomiting and diarrhea occurred mainly during escalation and decreased over time; that does not guarantee when your symptoms will stop. Persistent or worsening symptoms need review.
Does more nausea mean the medicine is working better? Do not use nausea as a target or as a reason to accept severe symptoms. Your care team evaluates benefit and tolerability together. Use the symptom tracker to describe how you feel, not to score treatment effectiveness.
Which medication causes the fewest side effects? Separate trials cannot settle that question for an individual. Our side-effect rates guide identifies the formulation and population behind each column. A change of medicine belongs in a discussion of your symptoms, treatment goals and medical history.
Can I get help through my telehealth provider? Check your actual care plan for messaging hours, urgent advice and follow-up access. Our provider reviews can help you examine those service details if you are choosing care. A comparison website, provider sales form or unanswered portal message is not emergency support.
Sources
- Wegovy prescribing information and Medication Guide, Novo Nordisk, accessed September 8, 2026
- Wegovy nausea-management suggestions, Novo Nordisk, accessed September 8, 2026
- Zepbound prescribing information, Eli Lilly, revised August 2026
- Zepbound Medication Guide, Eli Lilly, accessed September 8, 2026
- Treatment for Constipation, National Institute of Diabetes and Digestive and Kidney Diseases
- Treatment of Diarrhea, National Institute of Diabetes and Digestive and Kidney Diseases
- FDA requests removal of suicidal behavior and ideation warning, January 13, 2026
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.
Affiliate Disclosure: Provider reviews elsewhere on this site may contain affiliate links. Commissions do not determine our safety guidance.
Track your side effects privately
30-day severity heatmap. Stored on-device, never transmitted, no email required.
Related Reading
Keep exploring this topic
What the doctors say
Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.
“Muscle is more metabolically active than fat. A significant loss of muscle mass can lower a person's metabolic rate, making it more challenging to maintain weight loss in the long run.”
“Our research highlights the safety and the potential for GLP-1 receptor agonists to reduce the risk of acute pancreatitis recurrence in individuals with obesity and type 2 diabetes, challenging previous concerns and offering new hope for effective disease management.”
“Americans should be confident that the prescription drugs they take are safe. By strengthening oversight of imported APIs and cracking down on illegal drugs entering the U.S., we are taking aggressive action to protect consumers from poor-quality or dangerous GLP-1 drugs.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.